RayVio, a Hayward, CA-based provider of UV LED solutions, has emerged from stealth mode and raised $9.3m in Series B funding.
Backers included new investors Applied Ventures, Augment Ventures, New Ground Ventures and Tolero Ventures and existing investors DCM Ventures and Capricorn Investment Group.
The company intends to use the funds to accelerate its go-to-market strategy, grow its team, and enable mass adoption of UV LED solutions in the industrial, commercial and consumer sectors.
Led by Dr. Robert C. Walker, CEO, RayVio provides consumer disinfection solutions that are portable and durable. Its patent protected technology and materials, originally developed at Boston University by co-founders Dr. Yitao Liao and Prof. Theodore Moustakas, enable the mass adoption of UV LED solutions in the industrial, commercial and consumer sectors.
The technology will enalbe solutions for industrial curing, for UV medical treatment devices to treat ailments ranging from vitamin D deficiency to Multiple Sclerosis, and for the UV water, surface and air disinfection markets.